Tysabri News: Biogen profit, Tysabri sales disappoint

Tysabri News

	Timothy L. Vollmer, MD Professor Department of Neurology University of Colorado Health Sciences Center Co-Director of the RMMSC at Anschutz Medical Center and Medical Director-Rocky Mountain MS Center
My Educational Video on MS and MS Trials Produced by www.MSNewsChannel.com

Jennifer
Landry
News Editor

Josi
Creek
News Editor

Desinie
Smith
Senior News Editor

Patti
McArthur
News Editor

Erin
Tysabri
Editor

We Accept No Advertising

Founded 2004 by Stan Swartz

This site is run by Facebook Volunteers.

Visit our Facebook Page at:

facebook.com/StansAngels

400,000+ Facebook & MySpace Visitors! MS News Channel Visitors:

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS

CLICKING ON THE RED BUTTON BELOW

You'll get FREE Breaking News Alerts on new MS treatments as they are approved

PLUS: We will notify you when we produce videos like the one below that we filmed with Dr. Timothy Vollmer to help you understand Tysabri's temporary withdrawal from the market

Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center

Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."

- Jennifer Hartmark-Hill MD

Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."

"This is how I give myself a painless injection."

Heather Johnson

"A helpful tip for newly diagnosed MS patients."

"Important advice on choosing MS medication "

Joyce Moore

Previious Posts

MS NEWS ARCHIVES: by week

Tuesday, April 20

Biogen profit, Tysabri sales disappoint

(Posted By: Josi Creek)

Biogen Idec Inc (BIIB.O) said on Tuesday that first-quarter earnings fell 11 percent, hurt by one-time charges and lower-than-expected sales of its multiple sclerosis drug Tysabri.

To read the full story, click HERE

<< Home